Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News |  Saudi Arabia IVD Market is poised to reach US$ 700 Million by 2024Saudi Arabia IVD Market is poised to reach US$ 700 Million by the year 2024. Renub Research report titled "Saudi Arabia In Vitro Diagnostics Market, by Techniques, by Applications, by End User and by Companies" provides Saudi Arabia IVD Market.
By: Renub Research 
saudi-arabia ivd market-techniques-applications-co In-Vitro Diagnostic tests provide adequate information about the diseases without interacting directly to the human body. In-Vitro Diagnostic has numerous applications in disease diagnosing such as Infectious diseases, Oncology, Diabetes, Cardiovascular diseases, and others. IVD is used by physicians and clinicians at the various stages of the patient care pathway in hospitals, laboratories or other healthcare settings. With the increasing disease burden, the number of diagnostic tests in Saudi Arabia is also increasing and so is the In Vitro Diagnostics market of Saudi Arabia. Saudi Arabia IVD Market is poised to reach US$ 700 Million by the year 2024. With increasing cases of new strains of viruses and epidemic diseases, health experts are innovating unique healthcare solutions to improve the combat and cure for diseases. Among these innovations, In-vitro diagnostics plays a considerable role in saving people's lives by providing accurate diagnosis and prognosis, which further enables improved monitoring and treatment. Owing to the benefits offered by IVD, there is steady growth in its adoption and usage. Increasing incidences rates of infectious diseases and the lifestyle diseases are few factors, which are driving the Saudi Arabia In-Vitro Diagnostics (IVD) Market. Renub Research report titled "Saudi Arabia In Vitro Diagnostics (IVD) Market, by Techniques [Immunochemistry, Clinical Chemistry, Hematology, Hemostasis, Microbiology, Molecular Diagnostic, Self Monitoring of Blood Glucose (SMBG) and Point of Care Testing (POCT)]; by Applications (Infectious Diseases, Cardiovascular Diseases, Oncology, Diabetes and others); By End User (Government Labs & Hospitals, Private Labs & Hospitals and others) and by Companies (Roche, Abbott, Siemens Healthineers, Sysmex Corporation and Danaher Corporation)" Access full Research: https://www.renub.com/ By Technique – Immunochemistry, Clinical Chemistry and SMBG Driving the Saudi Arabia In-Vitro Diagnostics (IVD) Market The report studies the market of the following In-Vitro Diagnostics segments: Immunochemistry, Clinical Chemistry, Hematology, Hemostasis, Microbiology, Molecular Diagnostic, Self Monitoring of Blood Glucose (SMBG) and Point of Care Testing (POCT). Due to the rising infectious diseases, cancer cases and number of diabetics in the Kingdom of Saudi Arabia, it is believed that Saudi Arabia IVD Market will grow effortlessly in the coming years. By Application – Infectious Disease and Diabetes hold significant market of Saudi Arabia In-Vitro Diagnostics (IVD) Market On the basis of applications; By End User – Government Hospitals & Laboratory holds the Largest Market The report studies the market of the following End User segments: Government Labs & Hospitals, Private Labs & Hospitals and others. Companies Analysis Roche, Abbott, Siemens Healthineers, Sysmex Corporation and Danaher Corporation are some of the top companies operating in the In-Vitro Diagnostics; This market research report provides a complete analysis of the Saudi Arabia In-Vitro Diagnostics (IVD) Market, Growth Drivers, Challenges, and their projections for the upcoming years. By Technique • Immunochemistry • Clinical Chemistry • Hematology • Hemostasis • Microbiology • Molecular Diagnostic • Self Monitoring of Blood Glucose (SMBG) • Point of Care Testing (POCT) By Application • Infectious Diseases • Cardiovascular Diseases • Diabetes • Oncology • Others By End User • Government Labs & Hospitals • Private Labs & Hospitals • Others Company • Roche • Abbott • Siemens Healthineers • Sysmex Corporation • Danaher Corporation If the information you seek is not included in the current scope of the study kindly share your specific requirements with our custom research team at info@renub.com Contact Us Email: info@renub.com Phone: +1-678-302-0700 Web: www.renub.com End
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number